Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
暂无分享,去创建一个
H. Krumholz | Yuan Yu | E. Spatz | F. Masoudi | Jing Li | W. Schulz | Yuan Lu | Shuling Liu | Qi Tan
[1] H. Krumholz,et al. The China Patient-centered Evaluative Assessment of Cardiac Events (China PEACE) retrospective heart failure study design , 2018, BMJ Open.
[2] H. Krumholz,et al. Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China , 2018, Circulation. Cardiovascular quality and outcomes.
[3] Yue Liu,et al. Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications. , 2017, Current vascular pharmacology.
[4] Wei Wang,et al. A Review of Chinese Herbal Medicine for the Treatment of Chronic Heart Failure , 2017, Current pharmaceutical design.
[5] Shu Zhang,et al. Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial , 2017, Chinese medical journal.
[6] Y. Zhang,et al. Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms , 2017, Deutsche Zeitschrift für Akupunktur.
[7] Yu-Chiang Hung,et al. Prescription pattern of Chinese herbal products for heart failure in Taiwan: A population-based study. , 2017, International journal of cardiology.
[8] Lei Li,et al. Research review on the pharmacological effects of astragaloside IV , 2017, Fundamental & clinical pharmacology.
[9] G. Gobe,et al. The Antioxidant Effects of Radix Astragali (Astragalus membranaceus and Related Species) in Protecting Tissues from Injury and Disease. , 2016, Current drug targets.
[10] Tianlun Yang,et al. A randomized, double-blind, multicenter, placebo-controlled clinical study on the efficacy and safety of Shenmai injection in patients with chronic heart failure. , 2016, Journal of ethnopharmacology.
[11] Huamin Wei,et al. Shenfu decoction as adjuvant therapy for improving quality of life and hepatic dysfunction in patients with symptomatic chronic heart failure. , 2015, Journal of ethnopharmacology.
[12] L. Bao,et al. Hypolipidemic effect of safflower yellow and primary mechanism analysis. , 2015, Genetics and molecular research : GMR.
[13] Pei-hua Ren,et al. Effect of Yangxinkang Tablets (养心康片) on chronic heart failure: A multi-center randomized double-blind placebo-controlled trial , 2015, Chinese Journal of Integrative Medicine.
[14] Sombat Muengtaweepongsa,et al. CHInese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study (CHIMES-E): A Multicenter Study of Long-Term Efficacy , 2015, Cerebrovascular Diseases.
[15] Q. Zhang,et al. Effect of hydroxy safflower yellow A on myocardial apoptosis after acute myocardial infarction in rats. , 2015, Genetics and molecular research : GMR.
[16] C. Zhang,et al. Traditional Chinese medication for cardiovascular disease , 2015, Nature Reviews Cardiology.
[17] G. Xing,et al. Efficacy and Safety of Panax notoginseng Saponin Therapy for Acute Intracerebral Hemorrhage, Meta-Analysis, and Mini Review of Potential Mechanisms of Action , 2015, Front. Neurol..
[18] Wan‐chun Sun,et al. Phenolic Derivatives from Radix Astragali and their Anti-inflammatory Activities , 2014, Natural product communications.
[19] Fan Yang,et al. [Treatment of chronic heart failure of Xin-Shen yang deficiency, interior retention of water-fluid syndrome by external application of Zhuangshenling recipe combined with western medicine: a clinical study]. , 2014, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[20] Jiayi Cai,et al. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway. , 2014, Chemical & pharmaceutical bulletin.
[21] Suzhen Zhao,et al. Safflower yellow inhibits angiotensin II-induced adventitial fibroblast proliferation and migration. , 2014, Journal of pharmacological sciences.
[22] Xianliang Wang,et al. [Application and evaluation of Chinese medicine in treatment of chronic heart failure]. , 2013, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[23] W. Yao,et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. , 2013, Journal of the American College of Cardiology.
[24] F. Zhou,et al. Clinical Effects of Xinmailong Therapy in Patients with Chronic Heart Failure , 2013, International journal of medical sciences.
[25] Yong-ming Liu,et al. [Effects of suxiao jiuxin pill on patients with acute coronary syndrome undergoing early percutaneous coronary intervention]. , 2012, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[26] F. He,et al. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression. , 2012, Journal of ethnopharmacology.
[27] L. Gong,et al. [Treatment of chronic heart failure by shencao tongmai granule: a multi-centered, double-blinded, randomized, parallel controlled trial]. , 2012, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[28] Meng Chen,et al. Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation. , 2012, Vascular pharmacology.
[29] P. Little,et al. Cardiovascular actions and therapeutic potential of tanshinone IIA. , 2012, Atherosclerosis.
[30] Jie-ning Zhu,et al. Panax notoginseng saponins inhibit ischemia-induced apoptosis by activating PI3K/Akt pathway in cardiomyocytes. , 2011, Journal of ethnopharmacology.
[31] Ke-Ji Chen,et al. Progress in the research of Radix Astragali in treating chronic heart failure: Effective ingredients, dose-effect relationship and adverse reaction , 2011, Chinese journal of integrative medicine.
[32] Dong Zhou,et al. Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[33] Jimmy Tse-Jen Wang,et al. Protective effect of dried safflower petal aqueous extract and its main constituent, carthamus yellow, against lipopolysaccharide-induced inflammation in RAW264.7 macrophages. , 2011, Journal of the science of food and agriculture.
[34] Xiao-gang Sheng,et al. [Double blinded randomized and controlled study on treatment of chronic heart failure by nuanxin capsule]. , 2011, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[35] Xiumei Gao,et al. Clinical practice of traditional Chinese medicines for chronic heart failure , 2010, Heart Asia.
[36] Xingu Liu,et al. Traditional Chinese versus integrative treatment in elderly patients with isolated systolic hypertension: a multicenter, randomized, double-blind controlled trial. , 2010, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.
[37] A. Jahangir,et al. Use of herbal products and potential interactions in patients with cardiovascular diseases. , 2010, Journal of the American College of Cardiology.
[38] Jianming Lü,et al. Ginseng compounds: an update on their molecular mechanisms and medical applications. , 2009, Current vascular pharmacology.
[39] Jin-Ling Tang,et al. Traditional Chinese medicine , 2008, The Lancet.
[40] A. Lu,et al. Current situation and progress in integrative medicine in China , 2008, Chinese journal of integrative medicine.
[41] Xiao-hui Li,et al. PANAX NOTOGINSENG SAPONINS ATTENUATE ATHEROSCLEROSIS IN RATS BY REGULATING THE BLOOD LIPID PROFILE AND AN ANTI‐INFLAMMATORY ACTION , 2008, Clinical and experimental pharmacology & physiology.
[42] T. Cheng. Cardiovascular effects of Danshen. , 2007, International journal of cardiology.
[43] Eric Wong,et al. Use of traditional chinese medicine in the Hong Kong special administrative region of China. , 2007, Journal of alternative and complementary medicine.
[44] Hua Yu,et al. [Clinical observation on treatment of hypertension (yin-deficiency with sthenic-yang syndrome type) with Zhongfu Hypotension Capsule]. , 2007, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[45] Chen Ke-ji,et al. Situation of integrative medicine in China: Results from a national survey in 2004 , 2006 .
[46] Basile Chaix,et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena , 2006, Journal of Epidemiology and Community Health.
[47] Zhong Zuo,et al. Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use , 2005, Journal of clinical pharmacology.
[48] Amy Padula,et al. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. , 2005, Journal of general internal medicine.
[49] A. Heck,et al. Potential interactions between alternative therapies and warfarin. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[50] J. Zhang,et al. [Preventive effect of radix Astragali on insulin resistance caused by tumor necrosis factor-alpha]. , 1999, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[51] M. Gordon,et al. Inhibitory effect of Ginkgo biloba extract on human platelet aggregation. , 1999, Platelets.
[52] M. Griffiths,et al. Journal of the Science of Food and Agriculture , 1950, Nature.